Your cart is currently empty!
Recent news:
-
AstraZeneca to Acquire EsoBiotec for Up to $1 Billion to Boost Cell Therapy Portfolio
-
AstraZeneca Licenses Alteogen's ALT-B4 for Subcutaneous Cancer Therapies
-
Merck & Co.'s Winrevair Approved for Pulmonary Arterial Hypertension in Hainan
-
Visirna Therapeutics Announces Positive Phase III Results for Plozasiran in FCS Treatment
-
ROBO Medical's Innovative Gastrointestinal Endoscopic Instrument Gains NMPA Approval